Facilitating an open dialogue with patients, to better understand their needs, makes research efforts more valuable in the long-term
By
Andres Cervantes
However, there are still many obstacles faced by investigators in achieving effective patient involvement in research
By
Ornella Gonzato
Among all the stakeholders involved, oncology societies can play a pivotal role to facilitate efficient clinical investigations
By
Andres Cervantes
Despite generally disappointing clinical trial results, technological innovations mean that realising the potential for cancer vaccines could be just around the corner
By
Stephen P. Schoenberger
Conflicting clinical results on the benefits of combined radiotherapy and immunotherapy may derive from differences in treatment sequencing
By
Jean-Pascal Machiels
Conflicting clinical results on the benefits of combined radiotherapy and immunotherapy may derive from differences in treatment sequencing
By
Jean-Pascal Machiels
Despite generally disappointing clinical trial results, technological innovations mean that realising the potential for cancer vaccines could be just around the corner
By
Stephen P. Schoenberger
While some challenges associated with rare cancers are similar in Europe and Asia, resources and differing epidemiology need to be considered when coming up with solutions
By
Jyoti Bajpai
Results from a pilot study show that work–family balance is the biggest challenge to career progression for young women
By
Janice Tsang
A new level of sophistication, namely genome editing, is now available to help overcome previous hurdles with adoptive T-cell therapies
By
Chiara Bonini
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.